150 related articles for article (PubMed ID: 12627494)
21. Vaccine-strain varicella zoster virus causing recurrent herpes zoster in an immunocompetent 2-year-old.
Ota K; Kim V; Lavi S; Ford-Jones EL; Tipples G; Scolnik D; Tellier R
Pediatr Infect Dis J; 2008 Sep; 27(9):847-8. PubMed ID: 18664930
[TBL] [Abstract][Full Text] [Related]
22. DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccine.
Loparev VN; Rubtcova E; Seward JF; Levin MJ; Schmid DS
J Infect Dis; 2007 Feb; 195(4):502-10. PubMed ID: 17230409
[TBL] [Abstract][Full Text] [Related]
23. Prevention of shingles by varicella zoster virus vaccination.
Holodniy M
Expert Rev Vaccines; 2006 Aug; 5(4):431-43. PubMed ID: 16989624
[TBL] [Abstract][Full Text] [Related]
24. Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004.
Lopez AS; Burnett-Hartman A; Nambiar R; Ritz L; Owens P; Loparev VN; Guris D; Schmid DS
J Infect Dis; 2008 Mar; 197(5):646-53. PubMed ID: 18260757
[TBL] [Abstract][Full Text] [Related]
25. Analysis of repeat units in the R2 region among different Oka varicella-zoster virus vaccine strains and wild-type strains in Germany.
Sauerbrei A; Zell R; Wutzler P
Intervirology; 2007; 50(1):40-4. PubMed ID: 17164556
[TBL] [Abstract][Full Text] [Related]
26. Development and characterization of a live varicella vaccine (Oka strain).
Takahashi M
Biken J; 1984 Sep; 27(2-3):31-6. PubMed ID: 6100054
[TBL] [Abstract][Full Text] [Related]
27. Varicella-Zoster virus gene expression in latently infected rat dorsal root ganglia.
Kennedy PG; Grinfeld E; Bontems S; Sadzot-Delvaux C
Virology; 2001 Oct; 289(2):218-23. PubMed ID: 11689044
[TBL] [Abstract][Full Text] [Related]
28. Development of varicella vaccine.
Takahashi M; Asano Y; Kamiya H; Baba K; Ozaki T; Otsuka T; Yamanishi K
J Infect Dis; 2008 Mar; 197 Suppl 2():S41-4. PubMed ID: 18419406
[TBL] [Abstract][Full Text] [Related]
29. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
Breuer J; Whitley R
Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
[TBL] [Abstract][Full Text] [Related]
30. Detection and differentiation of wild-type and vaccine mutant varicella-zoster viruses using an Invader Plus method.
Tang YW; Allawi HT; DeLeon-Carnes M; Li H; Day SP; Schmid D
J Clin Virol; 2007 Oct; 40(2):129-34. PubMed ID: 17728179
[TBL] [Abstract][Full Text] [Related]
31. The varicella-zoster virus open reading frame 63 latency-associated protein is critical for establishment of latency.
Cohen JI; Cox E; Pesnicak L; Srinivas S; Krogmann T
J Virol; 2004 Nov; 78(21):11833-40. PubMed ID: 15479825
[TBL] [Abstract][Full Text] [Related]
32. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
Holcomb K; Weinberg JM
J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
[TBL] [Abstract][Full Text] [Related]
33. Allodynia in rats infected with varicella zoster virus--a small animal model for post-herpetic neuralgia.
Dalziel RG; Bingham S; Sutton D; Grant D; Champion JM; Dennis SA; Quinn JP; Bountra C; Mark MA
Brain Res Brain Res Rev; 2004 Oct; 46(2):234-42. PubMed ID: 15464211
[TBL] [Abstract][Full Text] [Related]
34. New method of differentiating wild-type varicella-zoster virus (VZV) strains from Oka varicella vaccine strain by VZV ORF 6-based PCR and restriction fragment length polymorphism analysis.
Takayama M; Takayama N
J Clin Virol; 2004 Feb; 29(2):113-9. PubMed ID: 14747030
[TBL] [Abstract][Full Text] [Related]
35. Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany.
Sauerbrei A; Wutzler P
J Med Virol; 2007 Jul; 79(7):1025-31. PubMed ID: 17516537
[TBL] [Abstract][Full Text] [Related]
36. Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus.
Quinlivan ML; Gershon AA; Steinberg SP; Breuer J
J Infect Dis; 2004 Aug; 190(4):793-6. PubMed ID: 15272408
[TBL] [Abstract][Full Text] [Related]
37. Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster.
Sauerbrei A; Rubtcova E; Wutzler P; Schmid DS; Loparev VN
J Clin Microbiol; 2004 Dec; 42(12):5604-8. PubMed ID: 15583288
[TBL] [Abstract][Full Text] [Related]
38. Immune evasion as a pathogenic mechanism of varicella zoster virus.
Abendroth A; Arvin AM
Semin Immunol; 2001 Feb; 13(1):27-39. PubMed ID: 11289797
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of glial fibrillary acidic protein expression during acute lytic varicella-zoster virus infection of cultured human astrocytes.
Kennedy PG; Major EO; Williams RK; Straus SE
Virology; 1994 Dec; 205(2):558-62. PubMed ID: 7975257
[TBL] [Abstract][Full Text] [Related]
40. Varicella-zoster virus latency in human ganglia.
Kennedy PG
Rev Med Virol; 2002; 12(5):327-34. PubMed ID: 12211045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
